Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease (Q44780252)

6 December 2017

Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease (English)

1 reference

6 December 2017

0 references

0 references

0 references

8

Raymond Vanholder

1 reference

6 December 2017

Christophe Tribouilloy

6

object named as

Christophe Tribouilloy

1 reference

6 December 2017

Daniela V Barreto

1

1 reference

6 December 2017

Fellype C Barreto

2

1 reference

6 December 2017

Sophie Liabeuf

3

1 reference

6 December 2017

Mohammed Temmar

4

1 reference

6 December 2017

Horst-Dieter Lemke

5

1 reference

6 December 2017

Gabriel Choukroun

7

1 reference

6 December 2017

Ziad A Massy

9

1 reference

6 December 2017

European Uremic Toxin Work Group (EUTox)

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

16 December 2009

1 reference

6 December 2017

1 reference

6 December 2017

77

1 reference

6 December 2017

6

1 reference

6 December 2017

550-556

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.503

6 December 2017

0 references

cites work

Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Elevated circulating levels of interleukin-6 in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Serum interleukin-6 in long-term hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Interleukin-6 exacerbates early atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

An Association between Aortic Pulse Wave Velocity, Blood Pressure and Chronic Inflammation in ESRD Patients on Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Effects of Atorvastatin on Inflammatory and Fibrinolytic Parameters in Patients with Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Confounding: propensity score adjustment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.503

7 January 2021

Identifiers

DOI

10.1038/KI.2009.503

1 reference

6 December 2017

1 reference